Collectively, the results suggest that LDMC with DOX effectively inhibits tumor growth via REDD1-dependent suppression of tumor endothelial VEGFR-2/3 expression, angiogenesis, and lymphangiogenesis. The gene discussed is KDR; the disease is neoplasm.